Results 171 to 180 of about 3,225,723 (227)

The Amyotrophic Lateral Sclerosis House Call Program: A Single-Center Experience in the United States. [PDF]

Neurol Res Int
Scirocco E, Scalia J, Ugolini B, Casagrande G, Ho D, Hagar JL, Kingsley K, Hoffman R, Cooley C, Cudkowicz ME, Paganoni S, Berry JD.   +11 more
europepmc   +1 more source

Plasma isomiRs as Candidate Biomarkers for Amyotrophic Lateral Sclerosis. [PDF]

Neurol Genet
Magee RG, Van Deerlin VM, McMillan CT, Lee EB, Elman LB, Irwin DJ, Mourelatos Z.   +6 more
europepmc   +1 more source

Excitotoxicity in amyotrophic lateral sclerosis: a key pathogenic mechanism. [PDF]

Brain Commun
Silva-Hucha S, Hernández RG, Baena-López D, Fernández de Sevilla ME, Paradas C, Morcuende S.   +5 more
europepmc   +1 more source

MATLAB-candexch algorithm-enhanced UV spectrophotometric-chemometric models for green, blue, and white determination of cinnarizine, domperidone, and carcinogenic impurity in pharmaceuticals: NQS assessment and UN-SDGs integration. [PDF]

BMC Chem
Ghanem HN, El-Zaher AA, Taha EA, Abbas AEF, Mahmoud ST.   +4 more
europepmc   +1 more source

Classification of ALS molecular subtypes: a literature review on machine learning applications and their clinical value. [PDF]

BMC Med
Jammal JK, Gomez EA, Al-Chalabi A, Iacoangeli A.   +3 more
europepmc   +1 more source

Biomechanical Voice Parameters as Potential Biomarkers for Phenotype Differentiation in Amyotrophic Lateral Sclerosis: A Cross-Sectional Study. [PDF]

Med Sci (Basel)
Pérez-Bonilla M, Mora-Ortiz M, Díaz-Borrego P, Muñoz-Alcaraz MN, Mayordomo-Riera FJ, Girela-López E.   +5 more
europepmc   +1 more source

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis. [PDF]

Nat Genet
Hop PJ, Kooyman M, Kenna BJ, Zwamborn RAJ, van Eijk KR, Wang Y, van Dijk CH, Bekema E, van Rheenen W, Beele P, van Vugt JJFA, Project MinE ALS sequencing Consortium, NYGC ALS Consortium, FALS sequencing Consortium, GTAC Consortium, Khleifat AA, Iacoangeli A, Cooper-Knock J, Smith BN, Topp S, van der Kooi AJ, Fominykh V, Drory V, Lerner Y, Shovman Y, Rowe DB, Williams KL, McLaughlin RL, Hurt J, Huang Y, Chen CY, Tsai E, Runz H, Aronica E, Groen EJN, van Es MA, Pasterkamp RJ, Farhan SMK, Garton FC, McRae AF, McCombe PA, Henderson RD, Fan D, Šlachtová L, Høyer H, Nishimura AL, Cauchi RJ, Brylev L, Rogelj B, Koritnik B, Zidar J, Salas T, Mora Pardina JS, Gotkine M, Povedano M, Corcia P, Vourc'h P, Couratier P, Weber M, Kiernan MC, Pamphlett R, Blair IP, de Carvalho M, Başak NA, Ingre C, Andersen PM, Zinman L, Rogaeva E, MacKenzie IR, Dupre N, Rouleau GA, Traynor BJ, Ticozzi N, Chiò A, Silani V, Hardiman O, Phatnani H, Harms MB, Dalgard CL, Glass JD, Landers JE, Van Damme P, Morrison KE, Shaw PJ, Shaw CE, Al-Chalabi A, van den Berg LH, Kenna KP, Veldink JH.   +88 more
europepmc   +1 more source

Reappraisal of the Diagnostic Significance of Transcranial Magnetic Stimulation and Triple Stimulation in Amyotrophic Lateral Sclerosis. [PDF]

Eur J Neurol
Andersen B, Krarup C.
europepmc   +1 more source